PATENT CLAIM ANALYSIS

Application Number: 15767099
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-03
Patent Classification: ["514", "04400R"]

Abstract:
The present disclosure is directed to methods and compositions for inhibiting a cancer cell using nucleic acid sequences encoding elephant p53 or elephant p53 amino acid sequences.

Claim (Index 32):
The method of  claim 1 , wherein the cancer cell is in vitro or in vivo.

Metadata:
- Claim Count in Document: 63.0
- Percentile: 91.0
- Lexical Diversity: 1.16667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12849261', '14232858', '14956635', '12253418', '12343104']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7369523681683288
- 35 USC 102 Novelty (BERT): 0.5197709271012317
- Combined Prediction Score: 0.7152342240616191
- Mean Citation Score: 242.221048
- Max Citation Score: 247.22247
- Similarity Product: 149.69355499572515

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test